T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Clean Harbors
CLH
$16.9B
| $113M | 0.02% |
2,092,421
-67,731
| -3% | -$3.67M |
|
602
Monro
MNRO
$352M
| $113M | 0.02% |
1,988,018
+13,060
| +0.7% | +$680K |
|
603
Red Robin
RRGB
$183M
| $113M | 0.02% |
2,002,006
+58,710
| +3% | +$3.38M |
|
604
Omnicom Group
OMC
$24.2B
| $112M | 0.02% |
1,542,205
-197,786
| -11% | -$14.2M |
|
605
Corning
GLW
$137B
| $112M | 0.02% |
3,503,901
+1,875,867
| +115% | +$59.1M |
|
606
Xencor
XNCR
$1.71B
| $112M | 0.02% |
5,093,271
+153,234
| +3% | +$3.32M |
|
607
Brink's
BCO
$4.72B
| $111M | 0.02% |
1,416,598
+8,970
| +0.6% | +$726K |
|
|
PPBI
608
DELISTED
Pacific Premier Bancorp
PPBI
| $111M | 0.02% |
2,780,883
-20,542
| -0.7% | -$808K |
|
|
PXD
609
DELISTED
Pioneer Natural Resource Co.
PXD
| $111M | 0.02% |
642,262
-144,153
| -18% | -$22.2M |
|
|
IDTI
610
DELISTED
Integrated Device Technology I
IDTI
| $111M | 0.02% |
3,726,685
+1,944,391
| +109% | +$58.5M |
|
611
Nektar Therapeutics
NKTR
$2.56B
| $111M | 0.02% |
123,375
+44,908
| +57% | +$26.6M |
|
612
Expro Ltd
XPRO
$2.1B
| $110M | 0.02% |
2,767,800
+64,352
| +2% | +$2.56M |
|
613
Halliburton
HAL
$27.4B
| $110M | 0.02% |
2,249,897
-11,513
| -0.5% | -$507K |
|
614
Steris
STE
$23B
| $109M | 0.02% |
1,243,776
-109,247
| -8% | -$9.75M |
|
615
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $109M | 0.02% |
4,313,495
+158,419
| +4% | +$3.96M |
|
|
AVX
616
DELISTED
AVX Corporation
AVX
| $109M | 0.02% |
6,275,432
+426,370
| +7% | +$7.8M |
|
617
Invesco
IVZ
$14.3B
| $108M | 0.02% |
2,951,549
-524,217
| -15% | -$19M |
|
|
STFC
618
DELISTED
State Auto Financial Corp
STFC
| $108M | 0.02% |
3,696,510
+17,352
| +0.5% | +$468K |
|
|
IMMU
619
DELISTED
Immunomedics Inc
IMMU
| $107M | 0.02% |
6,627,662
+251,530
| +4% | +$2.97M |
|
|
ROIC
620
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $106M | 0.02% |
5,329,794
-66,121
| -1% | -$1.27M |
|
|
B
621
DELISTED
Barnes Group Inc.
B
| $106M | 0.02% |
1,678,684
+7,070
| +0.4% | +$469K |
|
622
TherapeuticsMD
TXMD
$24.1M
| $105M | 0.02% |
348,628
+35,848
| +11% | +$9.98M |
|
623
Duke Energy
DUK
$97.1B
| $105M | 0.02% |
1,245,582
-38,409
| -3% | -$3.36M |
|
|
WPX
624
DELISTED
WPX Energy, Inc.
WPX
| $104M | 0.02% |
7,423,107
+500,664
| +7% | +$6.06M |
|
|
LL
625
DELISTED
LL Flooring Holdings, Inc.
LL
| $104M | 0.02% |
3,323,987
+484,930
| +17% | +$15.3M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.